---
schema_version: "secwatch.filing_event.v1"
accession: "0001062993-23-018163"
form_type: "8-K"
ticker: null
cik: "0001617765"
company_name: "EVOME MEDICAL TECHNOLOGIES INC."
filed_at: "2023-09-18T23:59:59+00:00"
generated_at: "2026-06-10T14:50:44.508176+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Salona Global subsidiary Biodex Medical Systems enters $3M secured revolving credit agreement with Pathward

## Summary
- Biodex Medical Systems, subsidiary of Salona Global, entered a secured revolving loan facility of up to $3.0 million from Pathward on September 12, 2023.
- Approximately $1.7 million was immediately available; variable interest rate equals greater of 6% per annum or prime + 0.75%.
- Loan is payable on demand and secured by personal property of Borrower, Salona Global, and several guarantors including Inspira Financial, Mio-Tech, Simbex, and DaMar.
- Debt complements existing credit facilities with Pathward through other subsidiaries; Guaranty executed by all guarantors.

## SEC filing metadata
- accession: 0001062993-23-018163
- form_type: 8-K
- cik: 0001617765
- company_name: EVOME MEDICAL TECHNOLOGIES INC.
- filed_at: 2023-09-18T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1617765/000106299323018163/0001062993-23-018163-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1617765/000106299323018163/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062993-23-018163
- JSON: https://secwatch.observer/filing/0001062993-23-018163.json
- Plain text: https://secwatch.observer/filing/0001062993-23-018163.txt

## Key facts
- Debt Financings
  EVOME MEDICAL TECHNOLOGIES INC. incurred guarantee with Pathward, National Association.
  - Instrument: guarantee
  - Counterparty: Pathward, National Association
  - Event: incurrence
  source text: (“Borrower”), entered into a Master Credit and Security Agreement and related Schedule with Pathward, National Association (“Lender”) to receive financing accommodations in the form of a secured revolving loan of up to $3.0 million (the "Agreement"), of which approximately US $1.7 million was available to be borrowed as of September 12, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1617765/000106299323018163/0001062993-23-018163-index.htm
- Debt Financings
  EVOME MEDICAL TECHNOLOGIES INC. incurred revolving credit of up to $3.0 million with Pathward, National Association at the greater of 6.00% per annum or 0.75% in excess of the rate shown in the Wall.
  - Instrument: revolving credit
  - Principal: up to $3.0 million
  - Counterparty: Pathward, National Association
  - Rate: the greater of 6.00% per annum or 0.75% in excess of the rate shown in the Wall
  - Event: incurrence
  source text: On September 12, 2023, an operating subsidiary of Salona Global Medical Device Corporation (“Company”), Biodex Medical Systems, Inc. (“Borrower”), entered into a Master Credit and Security Agreement and related Schedule with Pathward, National Association (“Lender”) to receive financing accommodations in the form of a secured revolving loan of up to $3.0 million (the "Agreement"), of which approximately US $1.7 million was available to be borrowed as of September 12, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1617765/000106299323018163/0001062993-23-018163-index.htm
- Material Agreements
  EVOME MEDICAL TECHNOLOGIES INC. entered into Master Credit and Security Agreement with Pathward, National Association valued at up to $3.0 million (effective 2023-09-12).
  - Action: entry
  - Agreement: credit facility
  - Counterparty: Pathward, National Association
  - Value: up to $3.0 million
  - Effective: 2023-09-12
  source text: On September 12, 2023, an operating subsidiary of Salona Global Medical Device Corporation (“Company”), Biodex Medical Systems, Inc. (“Borrower”), entered into a Master Credit and Security Agreement and related Schedule with Pathward, National Association (“Lender”) to receive financing accommodations in the form of a secured revolving loan of up to $3.0 million (the "Agreement")
  evidence_url: https://www.sec.gov/Archives/edgar/data/1617765/000106299323018163/0001062993-23-018163-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.